Functional and Structural Characterization of Factor Xa Dimer in Solution

被引:8
作者
Chattopadhyay, Rima [1 ,2 ]
Iacob, Roxana [3 ]
Sen, Shalmali [1 ,2 ]
Majumder, Rinku [1 ,2 ]
Tomer, Kenneth B. [3 ]
Lentz, Barry R. [1 ,2 ]
机构
[1] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC USA
[3] NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA
基金
美国国家卫生研究院;
关键词
BLOOD-COAGULATION FACTOR; FACTOR V-A; BINDING-SITE; HUMAN-PROTHROMBIN; MEMBRANE-BINDING; PROCOAGULANT LIPIDS; BOVINE PROTHROMBIN; CRYSTAL-STRUCTURE; PHOSPHATIDYLSERINE; ACTIVATION;
D O I
10.1016/j.bpj.2008.10.013
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Previous studies showed that binding of water-soluble phosphatidylserine (C6PS) to bovine factor Xa (FXa) leads to Ca2+-dependent dimerization in solution. We report the effects of Ca2+, C6PS, and dimerization on the activity and structure of human and bovine FXa. Both human and bovine dimers are 10(6)-to 10(7)-fold less active toward prothrombin than the monomer, with the decrease being attributed mainly to a substantial decrease in k(cat). Dimerization appears not to block the active site, since amidolytic activity toward a synthetic substrate is largely unaffected. Circular dichroism reveals a substantial change in tertiary or quaternary structure with a concomitant decrease in a-helix upon dimerization. Mass spectrometry identifies a lysine (K-270) in the catalytic domain that appears to be buried at the dinner interface and is part of a synthetic peptide sequence reported to interfere with factor Va (FVa) binding. C6PS binding exposes K-351 (part of a reported FVa binding region), K-242 (adjacent to the catalytic triad), and K-420 (part of a substrate exosite). We interpret our results to mean that C6PS-induced dimerization produces substantial conformational changes or domain rearrangements such that structural data on PS-activated FXa is required to understand the structure of the FXa dinner or the FXa-FVa complex.
引用
收藏
页码:974 / 986
页数:13
相关论文
共 58 条
[1]   Specificity of soluble phospholipid binding sites on human factor Xa [J].
Banerjee, M ;
Drummond, DC ;
Srivastava, A ;
Daleke, D ;
Lentz, BR .
BIOCHEMISTRY, 2002, 41 (24) :7751-7762
[2]   Role of procoagulant lipids in human prothrombin activation. 2. Soluble phosphatidylserine upregulates and directs factor Xa to appropriate peptide bonds in prothrombin [J].
Banerjee, M ;
Majumder, R ;
Weinreb, G ;
Wang, JF ;
Lentz, BR .
BIOCHEMISTRY, 2002, 41 (03) :950-957
[3]   The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor [J].
Banner, DW ;
DArcy, A ;
Chene, C ;
Winkler, FK ;
Guha, A ;
Konigsberg, WH ;
Nemerson, Y ;
Kirchhofer, D .
NATURE, 1996, 380 (6569) :41-46
[4]   CHANGES IN MEMBRANE PHOSPHOLIPID DISTRIBUTION DURING PLATELET ACTIVATION [J].
BEVERS, EM ;
COMFURIUS, P ;
ZWAAL, RFA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 736 (01) :57-66
[5]  
CHATTOPADHYAY A, 1992, J BIOL CHEM, V267, P12323
[6]   Fluorescence resonance energy transfer study of shape changes in membrane-bound bovine prothrombin and meizothrombin [J].
Chen, Q ;
Lentz, BR .
BIOCHEMISTRY, 1997, 36 (15) :4701-4711
[7]   A NEW MODEL TO DESCRIBE EXTRINSIC PROTEIN-BINDING TO PHOSPHOLIPID-MEMBRANES OF VARYING COMPOSITION - APPLICATION TO HUMAN COAGULATION PROTEINS - APPENDIX - A NEW MODEL TO DESCRIBE EXTRINSIC PROTEIN-BINDING TO PHOSPHOLIPID-MEMBRANES OF VARYING COMPOSITION - QUANTITATIVE DEVELOPMENT [J].
CUTSFORTH, GA ;
WHITAKER, RN ;
LENTZ, BR ;
HERMANS, J .
BIOCHEMISTRY, 1989, 28 (18) :7453-7461
[8]   THROMBIN [J].
FENTON, JW .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1986, 485 :5-15
[9]   CHARACTERIZATION OF AN ALMOST FULL-LENGTH CDNA CODING FOR HUMAN-BLOOD COAGULATION FACTOR-X [J].
FUNG, MR ;
HAY, CW ;
MACGILLIVRAY, RTA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) :3591-3595
[10]   SHIFTS IN THE CONCENTRATIONS OF MAGNESIUM AND CALCIUM IN EARLY PORCINE AND RAT WOUND FLUIDS ACTIVATE THE CELL MIGRATORY RESPONSE [J].
GRZESIAK, JJ ;
PIERSCHBACHER, MD .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :227-233